On December 18, 2018, a SeekingAlpha contributor published a 117-page adverse report about AxoGen.

The contributor’s investigation reportedly found in part “[a] number of former employees allege channel stuffing, given that the company’s consignment model creates potential for abuse, as well as alleging questionable revenue recognition practices” and “allegations additionally include misleading operating metrics, with one former rep implying that the company’s definition of ‘active accounts’ may overstate the actual number by a factor of ten.”

This news drove the price of AxoGen shares down $6.27, or about 23%, to close at $21.36 that day.

More recently, AxoGen’s Chief Commercial Officer and its VP U.S. Sales resigned.

“We’re focused on investors’ losses, the extent to which management may have engaged in improper promotional efforts and committed accounting irregularities, and the circumstances surrounding senior management turnover,” said Hagens Berman partner Reed Kathrein.

Whistleblowers: Persons with non-public information regarding AxoGen should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email AXGN@hbsslaw.com.

About Hagens Berman Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 80+ attorneys in 10 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.